Literature DB >> 15077076

Renal insufficiency and mortality from acute coronary syndromes.

Frederick A Masoudi1, Mary E Plomondon, David J Magid, Anne Sales, John S Rumsfeld.   

Abstract

BACKGROUND: Although there is accumulating evidence that renal insufficiency is an independent risk factor for mortality after acute myocardial infarction (AMI), it is not known whether renal dysfunction is associated with an increased mortality rate after a broad range of acute coronary syndromes, including unstable angina.
METHODS: We examined consecutive patients from 24 Veterans Affairs hospitals with confirmed AMI or unstable angina between March 1998 and February 1999, who were categorized into groups according to estimated glomerular filtration rate (GFR). Multivariable regression was used to assess the independent association between GFR and the 7-month mortality rate, adjusting for differences in patient characteristics and treatment.
RESULTS: Of the 2706 patients, 436 (16%) had normal renal function (GFR >90 mL/min/1.73 m(2)), 1169 (43%) had mild renal insufficiency (GFR 60-89 mL/min/1.73 m(2)), 864 (32%) had moderate renal insufficiency (GFR 30-59 mL/min/1.73 m(2)), and 237 (9%) had severe renal insufficiency (GFR <30 mL/min/1.73 m(2)). Patients with renal insufficiency were less likely to undergo coronary angiography or to receive aspirin or beta-blockers at discharge. In multivariable models, renal insufficiency was associated with a higher odds of death (mild renal insufficiency: odds ratio [OR] = 1.76; 95% CI, 0.93-3.33; moderate renal insufficiency: OR = 2.72; 95% CI, 1.43-5.15; and severe renal insufficiency: OR = 6.18; 95% CI, 3.09-12.36; all compared with normal renal function). The associations between renal insufficiency and mortality rate were similar in both the AMI and unstable angina subgroups (P value for interaction =.45).
CONCLUSIONS: Renal insufficiency is common and is associated with higher risks for death in patients with a broad range of ACS at presentation. Future efforts should be dedicated to determining whether more aggressive treatment will optimize outcomes in this patient population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077076     DOI: 10.1016/j.ahj.2003.12.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

1.  Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.

Authors:  Moritz Wagner; Rene Schilling; Patrick Doeblin; Alexander Huppertz; Reny Luhur; Carsten Schwenke; Martin Maurer; Bernd Hamm; Matthias Taupitz; Tahir Durmus
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

Review 2.  Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Authors:  David H Fitchett; Bjug Borgundvaag; Warren Cantor; Eric Cohen; Sanjay Dhingra; Stephen Fremes; Milan Gupta; Michael Heffernan; Heather Kertland; Mansoor Husain; Anatoly Langer; Eric Letovsky; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

3.  Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  J Mayich; Jafna L Cox; Karen J Buth; Jean-Francois Légaré
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

4.  Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.

Authors:  Mohammad I Zia; Shaun G Goodman; Eric D Peterson; Jyotsna Mulgund; Anita Y Chen; Anatoly Langer; Mary Tan; E Magnus Ohman; W Brian Gibler; Charles V Pollack; Matthew T Roe
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

Review 5.  Chronic kidney disease in acute coronary syndromes.

Authors:  Giancarlo Marenzi; Angelo Cabiati; Emilio Assanelli
Journal:  World J Nephrol       Date:  2012-10-06

6.  In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients.

Authors:  Ayman El-Menyar; Mohammad Zubaid; Kadhim Sulaiman; R Singh; Hassan Al Thani; Mousa Akbar; Bassam Bulbanat; Rashed Al-Hamdan; Wael Almahmmed; Jassim Al Suwaidi
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

7.  Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Miklos Rohla; Matthias K Freynhofer; Ioannis Tentzeris; Serdar Farhan; Johann Wojta; Kurt Huber; Thomas W Weiss
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-12-11

8.  Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.

Authors:  Dongting Liu; Xiaohai Ma; Jiayi Liu; Lei Zhao; Hui Chen; Lei Xu; Zhonghua Sun; Zhanming Fan
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-13       Impact factor: 2.357

9.  The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.

Authors:  James B Wetmore; Fengming Tang; Abhinav Sharma; Philip G Jones; John A Spertus
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

10.  Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies.

Authors:  Pamela N Peterson; Amrut V Ambardekar; Philip G Jones; Harlan M Krumholz; Erik Schelbert; John A Spertus; John S Rumsfeld; Frederick A Masoudi
Journal:  BMC Cardiovasc Disord       Date:  2009-07-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.